Screening early ovarian cancer early detection of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Ovary Epithelial Cells Prostate Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases56

Ovarian Neoplasms Uterine Cervical Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Prostatic Neoplasms Cystadenocarcinoma, Serous Lung Neoplasms Neoplasm Invasiveness Carcinoma Neoplasms Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Genetic Predisposition to Disease Pancreatic Neoplasms Disease Progression Neoplasm Recurrence, Local Colorectal Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Endometrial Neoplasms Peritoneal Neoplasms Carcinoma, Endometrioid Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Adenocarcinoma Ascites Cell Transformation, Neoplastic Precancerous Conditions Mouth Neoplasms Rectal Neoplasms Esophageal Neoplasms Genital Neoplasms, Female Liver Neoplasms Neovascularization, Pathologic Cystadenocarcinoma Neoplastic Syndromes, Hereditary Skin Neoplasms Fallopian Tube Neoplasms Head and Neck Neoplasms Neoplasms, Second Primary Melanoma Bone Neoplasms Disease Models, Animal Neoplasms, Multiple Primary Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Hormone-Dependent Carcinoma, Small Cell Hereditary Breast and Ovarian Cancer Syndrome Carcinoma in Situ Pharyngeal Neoplasms Neoplastic Cells, Circulating Breast Neoplasms, Male

Chemicals and Drugs51

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel Cancer Vaccines RNA, Messenger BRCA2 Protein DNA, Neoplasm BRCA1 Protein Antineoplastic Agents, Phytogenic Antigens, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Epididymal Secretory Proteins Receptor, erbB-2 Receptors, Estrogen Tumor Suppressor Protein p53 Antibodies, Monoclonal Carboplatin MicroRNAs DNA Primers Receptors, Progesterone Tumor Suppressor Proteins RNA, Neoplasm Receptor, Epidermal Growth Factor Tamoxifen Fluorouracil Antigens, Tumor-Associated, Carbohydrate DNA-Binding Proteins Antineoplastic Agents, Hormonal Taxoids Transcription Factors Biological Markers Proto-Oncogene Proteins Platinum Anticarcinogenic Agents Nuclear Proteins Deoxycytidine Carcinoembryonic Antigen Proto-Oncogene Proteins c-akt Organoplatinum Compounds Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Antibiotics, Antineoplastic Mucin-1 Platinum Compounds Estrogens Radiopharmaceuticals Topotecan

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Early Detection of Cancer Mammography Mass Screening Vaginal Smears Early Diagnosis Sensitivity and Specificity Prognosis Neoplasm Staging Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Survival Rate Reproducibility of Results Antineoplastic Combined Chemotherapy Protocols Prospective Studies Retrospective Studies Gene Expression Profiling Risk Factors Xenograft Model Antitumor Assays Follow-Up Studies Risk Risk Assessment Predictive Value of Tests Blotting, Western Disease-Free Survival Registries Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Odds Ratio Genetic Testing Immunohistochemistry Combined Modality Therapy Incidence Transplantation, Heterologous Enzyme-Linked Immunosorbent Assay Questionnaires Limit of Detection Kaplan-Meier Estimate Multivariate Analysis ROC Curve Treatment Outcome Immunoenzyme Techniques Chemotherapy, Adjuvant Drug Screening Assays, Antitumor Tumor Burden Tissue Array Analysis Neoplasm Grading Logistic Models Case-Control Studies DNA Mutational Analysis Clinical Trials as Topic SEER Program Flow Cytometry Transfection Biopsy Models, Biological Cohort Studies Molecular Targeted Therapy Confidence Intervals Breast Self-Examination False Positive Reactions Drug Administration Schedule Real-Time Polymerase Chain Reaction Gene Knockdown Techniques Disease Models, Animal Tomography, X-Ray Computed Immunoassay Radiotherapy Positron-Emission Tomography Prevalence Cluster Analysis Colonoscopy Feasibility Studies Pilot Projects Protein Array Analysis Evaluation Studies as Topic Diagnostic Imaging Mastectomy

Psychiatry and Psychology2

Smoking Breast Self-Examination

Phenomena and Processes46

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Genes, BRCA2 Mutation Risk DNA Methylation Germ-Line Mutation Cell Proliferation Time Factors Odds Ratio Genotype Apoptosis Cell Survival Base Sequence Cell Movement Down-Regulation Dose-Response Relationship, Drug Promoter Regions, Genetic Genes, Tumor Suppressor Cell Division Up-Regulation Cell Growth Processes Polymorphism, Genetic Cell Cycle Signal Transduction Algorithms Transfection Gene Silencing RNA Interference Genes, Neoplasm Gene Expression Phenotype Heterozygote Alleles Genes, p53 Postmenopause Drug Synergism Gene Amplification Epigenesis, Genetic Diet Phosphorylation CpG Islands Loss of Heterozygosity

Disciplines and Occupations4

Immunohistochemistry Medical Oncology Proteomics Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Incidence Questionnaires Base Sequence Molecular Sequence Data SEER Program Algorithms Prevalence

Named Groups3

Medically Uninsured Survivors European Continental Ancestry Group

Health Care39

Mass Screening Sensitivity and Specificity Survival Analysis Survival Rate Reproducibility of Results Prospective Studies Retrospective Studies Risk Factors Follow-Up Studies Risk Risk Assessment Predictive Value of Tests Disease-Free Survival Age Factors Registries National Cancer Institute (U.S.)Odds Ratio Genetic Testing Incidence Questionnaires Limit of Detection Kaplan-Meier Estimate Multivariate Analysis ROC Curve Treatment Outcome Logistic Models Case-Control Studies Clinical Trials as Topic SEER Program Cohort Studies Confidence Intervals American Cancer Society Genetic Counseling Prevalence Cluster Analysis Feasibility Studies Pilot Projects Evaluation Studies as Topic Age Distribution

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Early Detection of Cancer Mammography Uterine Cervical Neoplasms Mass Screening Medically Uninsured Breast Neoplasms Vaginal Smears United States Neoplasms, Glandular and Epithelial Early Diagnosis Sensitivity and Specificity CA-125 Antigen Tumor Markers, Biological Cell Line, Tumor Gene Expression Regulation, Neoplastic Prostatic Neoplasms Cystadenocarcinoma, Serous Genes, BRCA1 Lung Neoplasms Neoplasm Invasiveness Carcinoma Neoplasms Mice, Nude Prognosis Neoplasm Staging Antineoplastic Agents Neoplasm Metastasis Neoplasm Proteins Drug Resistance, Neoplasm Colonic Neoplasms Stomach Neoplasms Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Genetic Predisposition to Disease Survival Analysis Pancreatic Neoplasms Cisplatin Survival Rate Reproducibility of Results Antineoplastic Combined Chemotherapy Protocols Disease Progression Prospective Studies Retrospective Studies Gene Expression Profiling Genes, BRCA2 Risk Factors Paclitaxel Mutation Xenograft Model Antitumor Assays Follow-Up Studies Cancer Vaccines RNA, Messenger Neoplasm Recurrence, Local Risk BRCA2 Protein Colorectal Neoplasms DNA, Neoplasm Carcinoma, Squamous Cell DNA Methylation BRCA1 Protein Adenocarcinoma, Clear Cell Risk Assessment Predictive Value of Tests Adenocarcinoma, Mucinous Blotting, Western Disease-Free Survival Endometrial Neoplasms Peritoneal Neoplasms Carcinoma, Endometrioid Age Factors Registries Neoplasm Transplantation Tumor Cells, Cultured Oligonucleotide Array Sequence Analysis Urinary Bladder Neoplasms Germ-Line Mutation Antineoplastic Agents, Phytogenic Cell Proliferation Antigens, Neoplasm Carcinoma, Non-Small-Cell Lung Adenocarcinoma Time Factors Prostate-Specific Antigen National Cancer Institute (U.S.)Odds Ratio Genotype RNA, Small Interfering Genetic Testing Epididymal Secretory Proteins Immunohistochemistry Combined Modality Therapy Receptor, erbB-2 Apoptosis Ascites Cell Transformation, Neoplastic Receptors, Estrogen Tumor Suppressor Protein p53 Cell Survival Precancerous Conditions

No FAQ available that match "screening early ovarian cancer early detection of cancer"